Spectral AI, Inc. develops AI-driven medical diagnostics for wound care through its DeepView® System, a predictive diagnostic device and software platform for burn wound assessment. Company news centers on DeepView demonstrations at burn-care meetings, BARDA-supported development, FDA De Novo 510(k) submission activity, and preparation for U.S. commercialization.
Updates also cover quarterly and annual financial results, research and development revenue tied to government-supported work, cash resources, and executive or board leadership changes.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.